Guardian Capital Advisors (Canada)’s Bristol-Myers Squibb BMY Stock Holding History

Guardian Capital Advisors (Canada)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,800	Closed	-$300K	–	174
2023 Q4	$300K	Hold	5,800	–	–	0.03%	147
2023 Q3	$329K	Hold	5,800	–	–	0.04%	146
2023 Q2	$361K	Sell	5,800 -1,000	-15%	-$67.1K	0.04%	135
2023 Q1	$477K	Sell	6,800 -250	-4%	-$17.6K	0.06%	115
2022 Q4	$505K	Hold	7,050	–	–	0.06%	117
2022 Q3	$488K	Hold	7,050	–	–	0.06%	119
2022 Q2	$522K	Hold	7,050	–	–	0.06%	117
2022 Q1	$540K	Hold	7,050	–	–	0.05%	120
2021 Q4	$457K	Hold	7,050	–	–	0.04%	137
2021 Q3	$415K	Hold	7,050	–	–	0.04%	138
2021 Q2	$472K	Sell	7,050 -2,100	-23%	-$137K	0.05%	135
2021 Q1	$584K	Buy	9,150 +2,150	+31%	+$134K	0.07%	119
2020 Q4	$431K	Hold	7,000	–	–	0.06%	125
2020 Q3	$427K	Hold	7,000	–	–	0.07%	118
2020 Q2	$297K	Buy	7,000 +300	+4%	+$17.9K	0.06%	126
2020 Q1	$258K	Hold	6,700	–	–	0.06%	113
2019 Q4	$445K	Hold	6,700	–	–	0.06%	124
2019 Q3	$330K	Hold	6,700	–	–	0.04%	135
2019 Q2	$311K	Hold	6,700	–	–	0.04%	140
2019 Q1	$305K	Hold	6,700	–	–	0.04%	138
2018 Q4	$321K	Hold	6,700	–	–	0.05%	133
2018 Q3	$424K	Hold	6,700	–	–	0.06%	125
2018 Q2	$378K	Hold	6,700	–	–	0.05%	129
2018 Q1	$393K	Hold	6,700	–	–	0.06%	126
2017 Q4	$417K	Sell	6,700 -1,000	-13%	-$62.5K	0.05%	126
2017 Q3	$496K	Hold	7,700	–	–	0.07%	112
2017 Q2	$421K	Hold	7,700	–	–	0.06%	119
2017 Q1	$410K	Sell	7,700 -1,507	-16%	-$82.7K	0.06%	120
2016 Q4	$554K	Buy	+9,207	New	+$503K	0.08%	117
2016 Q3	–	Sell	-4,207	Closed	-$266K	–	162
2016 Q2	$266K	Hold	4,207	–	–	0.05%	137
2016 Q1	$244K	Sell	4,207 -800	-16%	-$50.5K	0.05%	142
2015 Q4	$275K	Sell	5,007 -1,000	-17%	-$66.1K	0.06%	136
2015 Q3	$301K	Buy	6,007 +107	+2%	+$6.79K	0.06%	133
2015 Q2	$344K	Sell	5,900 -1,500	-20%	-$98.9K	0.06%	136
2015 Q1	$494K	Sell	7,400 -450	-6%	-$28.2K	0.07%	133
2014 Q4	$516K	Sell	7,850 -400	-5%	-$22.6K	0.08%	127
2014 Q3	$434K	Sell	8,250 -1,500	-15%	-$74.9K	0.07%	132
2014 Q2	$450K	Hold	9,750	–	–	0.08%	136
2014 Q1	$466K	Hold	9,750	–	–	0.09%	129
2013 Q4	$517K	Hold	9,750	–	–	0.1%	127
2013 Q3	$450K	Sell	9,750 -1,000	-9%	-$43.9K	0.1%	133
2013 Q2	$452K	Buy	+10,750	New	+$467K	0.13%	109

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Guardian Capital Advisors (Canada)'s BMY Position: Q1 2024 in Review

Guardian Capital Advisors (Canada) sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 5,800 shares — an estimated $300K sold.

Guardian Capital Advisors (Canada) first reported a position in BMY in Q2 2013 and held it in 42 quarters. The position peaked at $584K in Q1 2021. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Guardian Capital Advisors (Canada) reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Guardian Capital Advisors (Canada) sold 5,800 Bristol-Myers Squibb shares in Q1 2024, an estimated $300K.
Guardian Capital Advisors (Canada) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 42 quarters.
Guardian Capital Advisors (Canada)'s Bristol-Myers Squibb position peaked at $584K in Q1 2021.
2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q1 2024, filed 14 May 2024.